Skip to content

Clinical trials

Thromboembolism trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: Brazil Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20082
20091
20121
20143
20161
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Boehringer Ingelheim3
Janssen Research & Development, LLC2
Daiichi Sankyo1
Johannes Gutenberg University Mainz1
Population Health Research Institute1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism14
Thrombosis4
Pulmonary Embolism3
Stroke3
Venous Thromboembolism3
Venous Thrombosis3
Ischemic Attack, Transient2
Atherosclerosis1
Atrial Fibrillation1
COVID-191

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.